How Important Is Controlling Risk Factors for the Prevention of a Stroke?

How Important Is Controlling Risk Factors for the Prevention of a Stroke?There has been a recent decline of about 20% to 40% in the incidence of cerebrovascular accidents (stroke). Although this is attributed to the improvement of risk factor control, the reason behind it is not utterly clear. This study estimated the impact of modifiable cardiovascular risk factors on the incidence of stroke between 1995 and 2012.

 

The risk of ischemic stroke was estimated by proportional regression among 26,329 participants in the register. The estimate was adjusted for unmodifiable risk factors such as age and gender.

 

There were 1226 new stroke cases per 36,7636 person-years of follow-up. Changes in risk factors accounted for 57% of the decrease in the incidence of this event from 1995 to 2012. The two factors that contributed the most to incidence decrease were systolic blood pressure (decreased by 26%) and smoking prevalence (decreased by 17%). Conversely, increasing diabetes prevalence contributed negatively to stroke incidence.

 

Conclusion

Changes in cardiovascular risk factors accounted for 57% of the decrease in stroke incidence. Reduction in systolic blood pressure and prevalence of smoking were the most important contributors.

 

Original title: Declining Incidence of Ischemic Stroke. What Is the Impact of Changing Risk Factors? The Tromso Study 1995 to 2012.

Reference: Anne M. Vangen-Lonne et al. Stroke. 2017 Feb 10. [Epub ahead of print].


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

AHA/ACC Guideline on the Management of Acute Pulmonary Embolism 2026

The 2026 ACC/AHA guideline for the management of acute pulmonary embolism (PE) introduces a conceptual shift by replacing the traditional “risk-based” classification with an...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...